ATE287952T1 - Humanes thymosin beta 15 gen,protein und dessen verwendungen - Google Patents

Humanes thymosin beta 15 gen,protein und dessen verwendungen

Info

Publication number
ATE287952T1
ATE287952T1 AT97929992T AT97929992T ATE287952T1 AT E287952 T1 ATE287952 T1 AT E287952T1 AT 97929992 T AT97929992 T AT 97929992T AT 97929992 T AT97929992 T AT 97929992T AT E287952 T1 ATE287952 T1 AT E287952T1
Authority
AT
Austria
Prior art keywords
thymosin beta
gene
protein
seq
members
Prior art date
Application number
AT97929992T
Other languages
English (en)
Inventor
Bruce R Zetter
Lere Bao
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of ATE287952T1 publication Critical patent/ATE287952T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97929992T 1996-06-17 1997-06-13 Humanes thymosin beta 15 gen,protein und dessen verwendungen ATE287952T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/664,856 US5663071A (en) 1996-06-17 1996-06-17 Human thymosin β 15 gene, protein and uses thereof
PCT/US1997/010315 WO1997048805A1 (en) 1996-06-17 1997-06-13 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF

Publications (1)

Publication Number Publication Date
ATE287952T1 true ATE287952T1 (de) 2005-02-15

Family

ID=24667732

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97929992T ATE287952T1 (de) 1996-06-17 1997-06-13 Humanes thymosin beta 15 gen,protein und dessen verwendungen

Country Status (9)

Country Link
US (2) US5663071A (de)
EP (1) EP0934412B1 (de)
JP (1) JP2000516086A (de)
AT (1) ATE287952T1 (de)
AU (1) AU732707B2 (de)
CA (1) CA2257855A1 (de)
DE (1) DE69732363T2 (de)
ES (1) ES2236813T3 (de)
WO (1) WO1997048805A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831033A (en) * 1997-02-14 1998-11-03 Children's Medical Center Of Boston Human thymosin β15 gene, protein and uses thereof
AU1085099A (en) * 1997-10-16 1999-05-03 Children's Medical Center Corporation Thymosin beta15 promoter and use thereof
US6218122B1 (en) 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
US20060100156A1 (en) * 2004-10-01 2006-05-11 Regenerx Biopharmaceuticals, Inc. Cell nucleus-entering compositions
US20070191275A1 (en) * 1998-07-30 2007-08-16 Regenerx Biopharmaceuticals, Inc. Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
US20080096817A1 (en) * 1998-07-30 2008-04-24 Regenerx Biopharmaceuticals, Inc. METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
US20040067227A1 (en) * 2001-11-02 2004-04-08 Goldstein Allan L. Inhibition or reversal of skin aging by actin-sequestering peptides
EP1100529B2 (de) * 1998-07-30 2010-08-25 The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health Thymosin beta 4 stimuliert wundheilung
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
US6642009B2 (en) 1999-05-17 2003-11-04 Cytyc Health Corporation Isolated ductal fluid sample
CN101549148A (zh) 2001-08-29 2009-10-07 雷根内克斯生物制药有限公司 多肽在制备用于促进心内膜细胞向间质细胞转化的药物中的应用
WO2007027578A2 (en) * 2005-08-31 2007-03-08 Regenerx Biopharmaceuticals, Inc. Methods and compositions for decreasing cohesivity of pathological respiratory tract secretions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045598A (ja) * 1983-04-07 1985-03-12 エフ．ホフマン−ラ　ロシユ　ウント　コンパニ−　アクチエンゲゼルシヤフト トリチウム化サイモシンβ４による免疫定量法

Also Published As

Publication number Publication date
EP0934412A1 (de) 1999-08-11
DE69732363D1 (de) 2005-03-03
ES2236813T3 (es) 2005-07-16
AU3392597A (en) 1998-01-07
AU732707B2 (en) 2001-04-26
US5663071A (en) 1997-09-02
EP0934412B1 (de) 2005-01-26
WO1997048805A1 (en) 1997-12-24
CA2257855A1 (en) 1997-12-24
US5721337A (en) 1998-02-24
JP2000516086A (ja) 2000-12-05
DE69732363T2 (de) 2005-12-22

Similar Documents

Publication Publication Date Title
Wilkinson Troponin C from rabbit slow skeletal and cardiac muscle is the product of a single gene
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
IL142905A0 (en) Functional antagonists of hedgehog activity
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69732363D1 (de) HUMANES THYMOSIN beta 15 GEN,PROTEIN UND DESSEN VERWENDUNGEN
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
NL300013I2 (nl) Nieuwe proteinen me TNF-remmende werking en hun bereiding.
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
DK0922223T3 (da) Fremgangsmåde til prognosticering af cancer
Maley et al. The primary structure of Lactobacillus casei thymidylate synthetase. I. The isolation of cyanogen bromide peptides 1 through 5 and the complete amino acid sequence of CNBr 1, 2, 3, and 5.
MY104909A (en) Peptide compounds.
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
HUP9900789A2 (hu) Lefelé irányuló szabályozásra rezisztens C3 konvertáz
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
WO2001098355A3 (en) Cgi-69 compositions and methods of use
BG105682A (en) Bone stimulating factor
DE69529235D1 (de) Menschliche dnase i varianten
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties